Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan

International Journal of Antimicrobial Agents

Volumn 35, Issue 2, 2010, Pages 201-202

  Liu, Jien Wei ^a   Jang, Tsrang Neng ^b   Cheng, Yu Jen ^c   Hsu, Gwo Jong ^d   Sun, Wu ^e   Lu, Chin Te ^f   Hsueh, Po Ren ^g  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^e Pao Chien Hospital   (Taiwan)

^f LOTUNG POH AI HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; CULTURE MEDIUM; EPSILOMETER TEST; INTERMETHOD COMPARISON; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; TAIWAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; TAIWAN;

EID: 72449173766     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.09.019     Document Type: Letter

References (7)

1. Falagas M.E., and Karveli E.A. The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect 13 (2007) 117-119
2. Karageorgopoulos D.E., Kelesidis T., Kelesidis I., and Falagas M.E. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother 62 (2008) 45-55
3. Liao C.H., Kung H.C., Hsu G.J., Lu P.L., Liu Y.C., Chen C.M., et al. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods. Int J Antimicrob Agents 32 Suppl. 3 (2008) S192-S196
4. Fernández Canigia L., Kaufman S., Lanata L., Vay C., Giovanakis M., Bantar C., and Argentinean Tigecycline Surveillance Group. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina. Chemotherapy 55 (2009) 20-27
5. Tiengrim S., Tribuddharat C., and Thamlikitkul V. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand. J Med Assoc Thai 89 Suppl. 5 (2006) S102-S105
6. Thamlikitkul V., and Tiengrim S. Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp. J Antimicrob Chemother 62 (2008) 847-848
7. Bradford P.A., Petersen P.J., Young M., Jones C.H., Tischler M., and O'Connell J. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob Agents Chemother 49 (2005) 3903-3909